mRNA
4 stories
-
healthModerna Receives $50 Million to Develop mRNA Ebola Vaccine
CEPI funds Moderna, IAVI, and Oxford to develop vaccines against the deadly Bundibugyo Ebola strain currently raging in the DRC.
-
healthEurope Approves Moderna's First mRNA Flu-COVID Vaccine, mCOMBRIAX
Moderna's mCOMBRIAX, the world's first mRNA combo vaccine for flu and COVID-19, receives European authorization, offering a simplified immunization option.
-
techEurope's Health Revolution: Women Driving Medical Breakthroughs
Discover the groundbreaking contributions of women in European biotech and medicine, from cancer tests to vaccines, and the ongoing fight for recognition.
-
healthSingle Vaccine Targets Flu and COVID-19, Shows Promising Results
New multicomponent mRNA vaccine demonstrates safety and robust immune response against influenza and COVID-19 in early trials.